InVivoMAb anti-mouse VEGF-A

Kaneko H, Kuroshima S, Kozutsumi R, et al. Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions. J Clin Med. 2023,12(5). doi: 10.3390/jcm12051914

Mashima T, Wakatsuki T, Kawata N, et al. Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo. Sci Rep. 2021,11(1):15125. doi: 10.1038/s41598-021-94584-9

Huang J, Kelly CP, Bakirtzi K, et al. Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis. Nat Microbiol. 2019,4(2):269-279. doi: 10.1038/s41564-018-0300-x

Lu R, Kujawski M, Pan H, et al. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. Cancer Res. 2012,72(9):2239-50. doi: 10.1158/0008-5472.CAN-11-3016

Kumar V, Scandella E, Danuser R, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010,115(23):4725-33. doi: 10.1182/blood-2009-10-250118

Basu A, Contreras AG, Datta D, et al. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 2008,68(14):5689-98. doi: 10.1158/0008-5472.CAN-07-6603